These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 26587776

  • 1. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE, Farrington CA, Wall GC, Belz MM.
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE.
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [Abstract] [Full Text] [Related]

  • 3. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J, Moffett BS.
    Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
    Mistry M, Shea A, Giguère P, Nguyen ML.
    Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188
    [Abstract] [Full Text] [Related]

  • 5. Management of hyperkalemia in hospitalized patients.
    Fordjour KN, Walton T, Doran JJ.
    Am J Med Sci; 2014 Feb; 347(2):93-100. PubMed ID: 23255245
    [Abstract] [Full Text] [Related]

  • 6. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.
    Watson M, Abbott KC, Yuan CM.
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253
    [Abstract] [Full Text] [Related]

  • 7. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2136-42. PubMed ID: 26576619
    [Abstract] [Full Text] [Related]

  • 8. Hyperkalemia and potential pitfalls of sodium polystyrene sulfonate.
    Nguyen T, Ondrik D, Zhufyak O, To W, He S.
    JAAPA; 2015 Mar 07; 28(3):41-5. PubMed ID: 25710403
    [Abstract] [Full Text] [Related]

  • 9. The Successful Treatment of Sodium Polystyrene Sulfonate-induced Enteritis Diagnosed by Small Bowel Endoscopy.
    Okayama K, Hirata Y, Kumai D, Yamamoto Y, Kojima Y, Kanno T, Ikeuchi H, Mochizuki H, Takada H, Sobue S.
    Intern Med; 2018 Jun 01; 57(11):1577-1581. PubMed ID: 29321412
    [Abstract] [Full Text] [Related]

  • 10. Asymptomatic Cecal Perforation in a Renal Transplant Recipient After Sodium Polystyrene Sulfonate Administration.
    Singla M, Shikha D, Lee S, Baumstein D, Chaudhari A, Carbajal R.
    Am J Ther; 2016 Jun 01; 23(4):e1102-4. PubMed ID: 25415544
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K, Flynn J, Okamura D, Zhou L.
    J Ren Nutr; 2013 Sep 01; 23(5):333-9. PubMed ID: 23707305
    [Abstract] [Full Text] [Related]

  • 12. Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia.
    Meyer I.
    ANNA J; 1993 Feb 01; 20(1):93-5. PubMed ID: 8431031
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Appropriate Sodium Polystyrene Sulfonate Use With a Hyperkalemia Order Set: A Pilot Study.
    Mueller ZT, Crannage AJ.
    J Pharm Pract; 2019 Oct 01; 32(5):493-498. PubMed ID: 29642732
    [Abstract] [Full Text] [Related]

  • 14. Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.
    Schaefer JA, Gales MA.
    Ann Pharmacother; 2016 Jun 01; 50(6):502-10. PubMed ID: 27009290
    [Abstract] [Full Text] [Related]

  • 15. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.
    Hasara S, Dubey J, Amatea J, Finnigan N.
    Am J Emerg Med; 2023 Mar 01; 65():59-64. PubMed ID: 36586223
    [Abstract] [Full Text] [Related]

  • 16. Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol.
    McGowan CE, Saha S, Chu G, Resnick MB, Moss SF.
    South Med J; 2009 May 01; 102(5):493-7. PubMed ID: 19373153
    [Abstract] [Full Text] [Related]

  • 17. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.
    Kessler C, Ng J, Valdez K, Xie H, Geiger B.
    J Hosp Med; 2011 Mar 01; 6(3):136-40. PubMed ID: 21387549
    [Abstract] [Full Text] [Related]

  • 18. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E, Ruegger M, Dunne I, Sutaria N, Towers WF.
    Am J Health Syst Pharm; 2023 Sep 07; 80(18):1238-1246. PubMed ID: 37335862
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT.
    Can J Kidney Health Dis; 2020 Sep 07; 7():2054358120965838. PubMed ID: 33240515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.